VBI Vaccines Inc

$2.04

0.14 7.32%

Last Updated: 2022-01-14 13:30:00

Volume: 2576100

Day's Range: 1.87 - 2.06

PREVIOUS CLOSE

$1.91

Description

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. The company primarily serves physicians and pharmacists through direct sales. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition For Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.

KEY DATA

Close
2.05000
$Chg
0.14000
Open
1.91000
High
2.06000
52 Weeks High
4.83
52 Weeks High Change
-2.78000
52 Weeks Change %
-57.55694
Average Volume
2648380
Currency
USD
Date Time
2022-01-14
Volume
2576100
%Chg
7.32984
Prev.Close
1.91000
Low
1.87000
52 Weeks Low
1.86
52 Weeks Low Change
0.19000
52 Weeks Low Change %
10.21505
Exchange
NASDAQ
52 Weeks Range
1.860000 - 4.830000

PERFORMANCE

Time Period
Close Price
7 Day
$2.06
1 Month
$2.5
3 Month
$3.19
6 Month
$2.98
1 Year
$3.29

Company Info

Profile

Symbol
VBIV
name
VBI Vaccines Inc
exchange
NASDAQ
sector
Healthcare
industry
Biotechnology
employees
127
type
Common Stock
CEO
Mr. Jeffrey R. Baxter F.C.M.A., FCMA
address
222 Third Street
City
Cambridge
ZIP
02142
State
MA
Country
US
Phone
617 830 3031
Dividends information:

payment date
2012-04-02
amount
0.25
Splits information:

date
2016-05-02
Description
1-for-40 split
Ratio
40
From Factor
1
To Factor
40

Statistic

Valuations Metrics

Market Capitalization
527475232
enterprise Value
490504096
30.162493
forward pe
-7.5925922
peg ratio
price to sales ttm
738.7608
price to book mrq
3.29582
enterprise to revenue
686.981
enterprise to ebitda
-8.234
Financials

Fiscal Year Ends
2020-12-31
most recent quarter
2021-09-30
profit margin
0
operating margin
-85.95518
return on assets ttm
-0.18101999
Income Statement

Revenue Ttm
714000
revenue per share ttm
0.003
quarterly revenue growth
-0.641
gross profit ttm
-8107000
ebitda
-59572000
net income to common ttm
-66332000
diluted eps ttm
-0.264
quarterly earnings growth yoy
Stock Price Summary

Fifty Two Week Low
1.86
fifty two week high
4.83
fifty two week change
beta
1.936623
day 50 ma
2.5656
day 200 ma
3.02655
Balance Sheet

Revenue Ttm
714000
total cash mrq
137470000
total cash per share mrq
0.534
total debt mrq
28454000
total debt to equity mrq
17.768
current ratio mrq
4.486
book value per share mrq
0.622
Cash Flow

Operating Cash Flow Ttm
-37887000
levered free cash flow ttm
-14811000
Stock Statistics

Shares Outstanding
257304992
float shares
190526462
avg 10 volume
2648380
avg 30 volume
3263443
shares short
18835769
short ratio
3.2
shortpercent of shares.....
0.1004
percent held by insiders
0.00524
percent held by institutions
0.47502
Dividends And Splits

Forward Annual Dividend Rate
forward annual dividend yield
trailing annual dividend rate
trailing annual dividend yield
5 year average dividend yield
payout ratio
0
dividend date
2012-12-28
ex dividend date
last split factor
1-for-40 split
last split date
2016-05-02

Balance Sheet

Assets

Current Assets
...
cash
cash equivalents
other short term investments
25276000
accounts receivable
130000
other receivables
7830000
inventory
2152000
Other Current Assets
1312000
total current assets
130472000
non current assets
...
properties
1554000
land and improvements
machinery furniture equipment
6160000
leases
8171000
Accumulated Depreciation
-3610000
goodwill
66678000
intangible assets
62156000
investments and advances
other non current assets
639000
total non current assets
12914000
total assets
143386000
Liabilities

Current Liabilities
...
accounts payable
2059000
accrued expenses
11233000
short term debt
944000
deferred revenue
255000
other current liabilities
1182000
total current liabilities
6115000
Non Current Laiabilities
...
long term debt
16948000
provision for risks and charges
deferred liabilities
other non current liabilities
total non current liabilities
16948000
total liabilities
23063000
Shareholders Equity
...
common stock
403528000
retained earnings
-308618000
other shareholders equity
1265000
other shareholders equity
1265000
total shareholders equity
96175000

Cash Flow

Balance Sheet

Fiscal Date
2020-12-31
operating activities
...
net income
-46230000
depreciation
1652000
deferred taxes
stock based compensation
5287000
other non cash items
386000
accounts receivable
130000
accounts payable
2059000
other assets liabilities
-10838000
operating cash flow
-47554000
investing activities
...
capital expenditures
-1000000
net acquisitions
purchase of investments
-25000000
sale of investments
other investing activity
investing cash flow
-26000000
financing activities
...
long term debt Issuance
20000000
long term debt payments
-15300000
short term debt issuance
common stock issuance
122185000
common dividends
other financing charges
-6633000
financing cash flow
120252000
end cash position
93825000
income tax paid
interest paid
1608000
free cash flow
-46554000

Watchlist

Customize Your MarketWatch

Never miss an update on your favorite companies and indexes.

A Wealth of Trading Knowledge

Head to our Education Center right now to view a plethora of trading mentorship videos and access an ever-growing library of investing books.

Insider Transactions

Full Name Position Date Reported Is Direct shares value description
ANDERSON DAVID EVANDER Officer 2019-06-14 1 21875
DEWILDE MICHEL Director 2019-06-14 1 12500
ANDERSON DAVID EVANDER Officer 2019-01-31 1 25000 0 Stock Award(Grant) at price 0.00 per share.
MAZALTOV AVI Officer 2019-01-31 1 90000 0 Stock Award(Grant) at price 0.00 per share.

Key Executives

Name Title Age Year Born pay

Institutional Holders

Entity Name Date Reported Shares Value percent held

Fund Holders

Entity Name Date Reported Shares Value percent held

IPO Calender

IPO Listing Symbol Name Exchange price range low price range High Offer Price Currency Shares
2022-01-19 EXCVV Exelon Corporation Common Stock Ex-Distribution When-Issued NASDAQ USD
2022-01-19 NSTS NSTS Bancorp, Inc. Common Stock NASDAQ 9.6 9.6 USD

Watchlist

Customize Your MarketWatch

Never miss an update on your favorite companies and indexes.

A Wealth of Trading Knowledge

Head to our Education Center right now to view a plethora of trading mentorship videos and access an ever-growing library of investing books.

WAIT!